On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

Learn more about whether LeMaitre Vascular, Inc. or Lantheus Holdings, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Researchers have developed a personalized blood test that may offer a faster, less invasive way to track high-grade glioma progression.

Fred Hutch oncologists found evidence of a tumor overlooked by others that extended from the base of the skull to the ear and ...